Each filer's latest filing for 83422E204 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Perceptive Advisors LLC
13D/A
|
11.2% |
8/14/2026
Event 6/30/2026
|
||
| Perceptive Advisors LLC | 11.2% | |||
| Joseph Edelman | 11.2% | |||
| Perceptive Life Sciences Master Fund, Ltd. | 11.2% | |||
| Perceptive Xontogeny Venture Fund, LP | 0.1% | |||
|
RA Capital Management, L.P.
13D/A
|
10.8% |
11/6/2026
Event 11/4/2026
|
||
| RA Capital Management, L.P. | 10.8% | |||
| Peter Kolchinsky | 10.8% | |||
| Rajeev Shah | 10.8% | |||
| RA Capital Healthcare Fund, L.P. | 10.7% | |||
|
Invus Global Management, LLC
13G/A
|
10.0% |
5/5/2026
Event 3/31/2026
|
||
| Invus Public Equities, L.P. | 8.7% | |||
| Invus Public Equities Advisors, LLC | 8.7% | |||
| Invus Global Management, LLC | 8.7% | |||
| Siren, L.L.C. | 8.7% | |||
| Avicenna Life Sci Master Fund LP | 1.4% | |||
| Avicenna Life Sci Master GP LLC | 1.4% | |||
| Ulys, L.L.C. | 1.4% | |||
| Raymond Debbane | 10.0% | |||
|
FMR LLC
13G
|
7.0% |
8/6/2026
Event 6/30/2026
|
||
| FMR LLC | 7.0% | |||
| Abigail P. Johnson | 7.0% | |||
| BlackRock, Inc. 13G | 6.5% |
7/30/2026
Event 6/30/2026
|
||
|
RTW Investments, LP
13G
|
5.5% |
11/16/2026
Event 9/30/2026
|
||
| RTW Investments, LP | 5.5% | |||
| Roderick Wong | 5.5% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (3) | ||||
|
Vestal Point Capital, LP
13G/A
|
4.8% |
8/14/2026
Event 6/30/2026
|
||
| Vestal Point Capital, LP | 4.8% | |||
| Ryan Wilder | 4.8% | |||
|
Adage Capital Management, L.P.
13G/A
|
1.8% |
2/12/2026
Event 12/31/2025
|
||
| Adage Capital Management, L.P. | 1.8% | |||
| Robert Atchinson | 1.8% | |||
| Phillip Gross | 1.8% | |||
|
Commodore Capital LP
13G/A
|
0% |
8/14/2025
Event 6/30/2025
|
||
| Commodore Capital LP | 0% | |||
| Commodore Capital Master LP | 0% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 158 | 119 M | $857M |
| 2026 Q2 | 156 | 115 M | $1.14B |
| 2026 Q1 | 144 | 99.7 M | $717M |
| 2025 Q4 | 125 | 81.4 M | $459M |
| 2025 Q3 | 122 | 81.4 M | $502M |
| 2025 Q2 | 112 | 82.2 M | $400M |
| 2025 Q1 | 123 | 78.8 M | $292M |
| 2024 Q4 | 92 | 36.3 M | $145M |
| 2024 Q3 | 96 | 35.9 M | $250M |
| 2024 Q2 | 81 | 37.6 M | $213M |
| 2024 Q1 | 57 | 35.0 M | $466M |
| 2023 Q4 | 41 | 16.6 M | $102M |
| 2023 Q3 | 37 | 16.2 M | $40.7M |
| 2023 Q2 | 35 | 16.3 M | $85.6M |
| 2023 Q1 | 38 | 15.8 M | $74.8M |
| 2022 Q4 | 36 | 15.3 M | $85.6M |
| 2020 Q3 | 1 | 307 k | $623k |